BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 20, 2017
View Archived Issues
Bonti secures series B financing to support development of EB-001
Read More
Phase III trial studies Solucin for neuroendocrine tumors of gastroenteric or pancreatic origin
Read More
BAY-1895344: a potent candidate for DNA damage-related tumors
Read More
New phase III trial explores use of nintedanib in progressive fibrosing lung conditions
Read More
Abeome and CDC establish Zika collaboration
Read More
Parvus signs license and collaboration agreement with Novartis in type 1 diabetes
Read More
A-395 is a first-in-class antagonist of PRC2 protein-protein interactions
Read More
H3 Biomedicine identifies selective estrogen receptor covalent antagonist H3B-6545 for breast cancer
Read More
Results from the TRUE-AHF trial of ularitide in patients with acute heart failure
Read More
Bicycle reports preclinical milestone under ThromboGenics ophthalmology alliance
Read More
AbbVie initiates phase III study of ABT-494 for psoriatic arthritis
Read More
New chewable tablet formulation of Vyvanse available in U.S.
Read More
MedImmune begins first-in-human study of MEDI-5083 alone and with durvalumab in solid tumors
Read More
Phase I/IIa trial of FOL-005 demonstrates stimulation of hair growth in healthy volunteers
Read More
Vernalis and Servier patent DYRK1 and CLK1 inhibitors
Read More
Lion Biotechnologies and MD Anderson establish TIL therapy alliance
Read More
Oncochel Therapeutics identifies thiosemicarbazone iron chelators
Read More
Oragenics provides update regarding AG-013 and OG-716
Read More
Xenon Pharmaceuticals and Genentech present Nav1.7 channel blockers
Read More
Johnson & Johnson reports key milestones of first quarter 2017
Read More
Incyte discovers Pim kinases inhibitors
Read More
Zejula now available in U.S.
Read More
BioCryst Pharmaceuticals presents plasma kallikrein inhibitors
Read More
Qu Biologics reports response and remission rates from trial of Qbeco in Crohn's disease
Read More
PLx Pharma completes merger with Dipexium Pharmaceuticals
Read More
Phase III studies of veliparib in NSCLC and TNBC did not meet primary endpoints
Read More
Cancer Research UK, CPF and NCI collaborate to target RAS
Read More
